<SEC-DOCUMENT>0000895345-17-000322.txt : 20171106
<SEC-HEADER>0000895345-17-000322.hdr.sgml : 20171106
<ACCEPTANCE-DATETIME>20171106090218
ACCESSION NUMBER:		0000895345-17-000322
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20171101
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20171106
DATE AS OF CHANGE:		20171106

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Merck & Co., Inc.
		CENTRAL INDEX KEY:			0000310158
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				221918501
		STATE OF INCORPORATION:			NJ
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-06571
		FILM NUMBER:		171178413

	BUSINESS ADDRESS:	
		STREET 1:		2000 GALLOPING HILL ROAD
		CITY:			KENILWORTH
		STATE:			NJ
		ZIP:			07033
		BUSINESS PHONE:		908-740-4000

	MAIL ADDRESS:	
		STREET 1:		2000 GALLOPING HILL ROAD
		CITY:			KENILWORTH
		STATE:			NJ
		ZIP:			07033

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Merck & Co. Inc.
		DATE OF NAME CHANGE:	20091103

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SCHERING PLOUGH CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>jb8k_merck.htm
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: Fried, Frank, Harris, Shriver & Jacobson LLP
    Document created using EDGARfilings PROfile 4.3.3.0
    Copyright 1995 - 2017 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" bgcolor="#ffffff" text="#000000">
<div>&#160;</div>

<div>
<div>
<hr style="BORDER-TOP: black 4px solid; HEIGHT: 10px; BORDER-BOTTOM: black 1px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
</div>

<div style="FONT-SIZE: 14pt; FONT-WEIGHT: bold; TEXT-ALIGN: center">&#160;</div>

<div style="FONT-SIZE: 14pt; FONT-WEIGHT: bold; TEXT-ALIGN: center">UNITED STATES</div>

<div style="FONT-SIZE: 14pt; FONT-WEIGHT: bold; TEXT-ALIGN: center">SECURITIES AND EXCHANGE COMMISSION</div>

<div style="FONT-SIZE: 12pt; FONT-WEIGHT: bold; TEXT-ALIGN: center">Washington, D.C.&#160; 20549</div>

<div><br>
</div>

<div style="FONT-SIZE: 18pt; FONT-WEIGHT: bold; TEXT-ALIGN: center">FORM 8-K</div>

<div>&#160;</div>

<div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">CURRENT REPORT</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Pursuant to Section 13 or 15(d) of</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">the Securities Exchange Act of 1934</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">Date of Report (Date of earliest event reported) <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">November 6, 2017</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 18pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Merck &amp; Co., Inc.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">(Exact Name of Registrant as Specified in Its Charter)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">New Jersey</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">(State or Other Jurisdiction of Incorporation)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>

<table id="z6265acd46745480591f74d9c82bc0b44" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 49%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">1-6571</div>
</td>
<td style="WIDTH: 2%; VERTICAL-ALIGN: bottom">
<div style="FONT-SIZE: 1pt; FONT-FAMILY: 'Times New Roman', serif; FONT-WEIGHT: bold; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>
</td>
<td style="WIDTH: 49%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">22-1918501</div>
</td>
</tr>

<tr>
<td style="WIDTH: 49%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">(Commission File Number)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>
</td>
<td style="WIDTH: 2%; VERTICAL-ALIGN: bottom">
<div style="FONT-SIZE: 1pt; FONT-FAMILY: 'Times New Roman', serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>
</td>
<td style="WIDTH: 49%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">(I.R.S. Employer Identification No.)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>
</table>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; TEXT-INDENT: 22.5pt">&#160;</div>

<table id="zbc7cd93efb9a47b29c030122755eb64f" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 49%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">2000 Galloping Hill Road, Kenilworth, NJ</div>
</td>
<td style="WIDTH: 2%; VERTICAL-ALIGN: bottom">
<div style="FONT-SIZE: 1pt; FONT-FAMILY: 'Times New Roman', serif; FONT-WEIGHT: bold; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>
</td>
<td style="WIDTH: 49%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">07033</div>
</td>
</tr>

<tr>
<td style="WIDTH: 49%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">(Address of Principal Executive Offices)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>
</td>
<td style="WIDTH: 2%; VERTICAL-ALIGN: bottom">
<div style="FONT-SIZE: 1pt; FONT-FAMILY: 'Times New Roman', serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>
</td>
<td style="WIDTH: 49%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">(Zip Code)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>
</table>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 36pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">Registrant's Telephone Number, Including Area Code <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">(908) 740-4000</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Not Applicable</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">(Former Name or Former Address, if Changed Since Last Report)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#9744;</font><font style="FONT-SIZE: 3pt; FONT-FAMILY: 'Times New Roman', serif">&#160;</font>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#9744;</font><font style="FONT-SIZE: 3pt; FONT-FAMILY: 'Times New Roman', serif">&#160;</font>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#9744;</font><font style="FONT-SIZE: 3pt; FONT-FAMILY: 'Times New Roman', serif">&#160;</font>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#9744;</font><font style="FONT-SIZE: 3pt; FONT-FAMILY: 'Times New Roman', serif">&#160;</font>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;204.12b-2 of this chapter)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#9744;</font><font style="FONT-SIZE: 3pt; FONT-FAMILY: 'Times New Roman', serif">&#160;</font>Emerging growth company</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#9744;</font></div>

<br>
</div>

<div>&#160;</div>

<div>&#160;</div>

<div>
<hr style="BORDER-TOP: black 1px solid; HEIGHT: 10px; BORDER-BOTTOM: black 4px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div>
<div style="TEXT-ALIGN: justify">&#160;</div>

<div style="TEXT-ALIGN: justify">&#160;</div>

<div style="TEXT-ALIGN: justify">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Item 8.01. Other Events</u></font>.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Attached as Exhibit 99.1 and incorporated by reference herein is a press release, dated November 6, 2017, issued by Merck &amp; Co., Inc.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"><u>Item 9.01. Financial Statements and Exhibits.</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; TEXT-INDENT: 18pt">(d)<font style="FONT-SIZE: 3pt; FONT-FAMILY: 'Times New Roman', serif">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Exhibits</u></font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>

<table id="z9b1b245903554644848787d50e94e975" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 13.86%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Exhibit 99.1</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>
</td>
<td style="WIDTH: 2.97%; VERTICAL-ALIGN: bottom">
<div style="FONT-SIZE: 1pt; FONT-FAMILY: 'Times New Roman', serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>
</td>
<td style="WIDTH: 83.18%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Press release issued November 6, 2017, regarding tender offer launch.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>
</table>

<div style="MARGIN-BOTTOM: 12pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-TOP: 12pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; TEXT-INDENT: 18pt">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center"><u>EXHIBIT INDEX</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>

<table id="zc3974f4d22ae486184e5c24713491312" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 10%; VERTICAL-ALIGN: bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left">Exhibit</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>
</td>
<td style="WIDTH: 3%; VERTICAL-ALIGN: bottom">
<div style="FONT-SIZE: 1pt; FONT-FAMILY: 'Times New Roman', serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>
</td>
<td style="WIDTH: 87%; VERTICAL-ALIGN: bottom">
<div style="FONT-SIZE: 1pt; FONT-FAMILY: 'Times New Roman', serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 10%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left">Number</div>
</td>
<td style="WIDTH: 3%; VERTICAL-ALIGN: bottom">
<div style="FONT-SIZE: 1pt; FONT-FAMILY: 'Times New Roman', serif; FONT-WEIGHT: bold; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>
</td>
<td style="WIDTH: 87%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Description</div>
</td>
</tr>

<tr>
<td style="WIDTH: 10%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>
</td>
<td style="WIDTH: 3%; VERTICAL-ALIGN: bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>
</td>
<td style="WIDTH: 87%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 10%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">99.1</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>
</td>
<td style="WIDTH: 3%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 1pt; FONT-FAMILY: 'Times New Roman', serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>
</td>
<td style="WIDTH: 87%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Press release issued November 6, 2017, regarding tender offer launch.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 10%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>
</td>
<td style="WIDTH: 3%; VERTICAL-ALIGN: bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>
</td>
<td style="WIDTH: 87%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>
</table>

<div style="MARGIN-BOTTOM: 12pt; MARGIN-TOP: 12pt"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center"><u>SIGNATURES</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; TEXT-INDENT: 36pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>
</div>
</div>

<div>&#160;</div>

<div>
<table id="z0d805200b99b459aa17c22dcca5074c7" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%; BORDER-COLLAPSE: separate" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 50%" valign="top">&#160;</td>
<td style="WIDTH: 38%; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="top" colspan="2"><strong>Merck &amp; Co., Inc.</strong></td>
<td style="WIDTH: 12%" valign="top">&#160;</td>
</tr>

<tr style="HEIGHT: 16px">
<td style="WIDTH: 50%" valign="top">&#160;</td>
<td style="WIDTH: 3%" valign="top">&#160;</td>
<td style="WIDTH: 35%" valign="top">&#160;</td>
<td style="WIDTH: 12%" valign="top">&#160;</td>
</tr>

<tr style="HEIGHT: 20px">
<td style="WIDTH: 50%; PADDING-BOTTOM: 2px" valign="top" align="left">
<div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">Date:&#160; November 6, 2017</div>
</td>
<td style="WIDTH: 3%; PADDING-BOTTOM: 2px" valign="top">
<div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">By: </div>
</td>
<td style="WIDTH: 35%; BORDER-BOTTOM: #000000 2px solid" valign="top" nowrap="nowrap" align="left">/s/&#160;Karen L. Mealey</td>
<td style="WIDTH: 12%; PADDING-BOTTOM: 2px" valign="top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 50%" valign="top">&#160;</td>
<td style="WIDTH: 3%" valign="top">&#160;</td>
<td style="WIDTH: 35%" valign="bottom" nowrap="nowrap" align="left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">KAREN L. MEALEY</div>
</td>
<td style="WIDTH: 12%" valign="top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 50%" valign="top">&#160;</td>
<td style="WIDTH: 3%" valign="top">&#160;</td>
<td style="WIDTH: 35%" valign="top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Assistant Secretary</div>
</td>
<td style="WIDTH: 12%" valign="top">&#160;</td>
</tr>
</table>
</div>

<div>&#160;</div>

<div>&#160;</div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99.htm
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: Fried, Frank, Harris, Shriver & Jacobson LLP
    Document created using EDGARfilings PROfile 4.3.3.0
    Copyright 1995 - 2017 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" bgcolor="#ffffff" text="#000000">
<div style="TEXT-ALIGN: right">&#160;</div>

<div style="TEXT-ALIGN: right"><br>
<font style="FONT-WEIGHT: bold">Exhibit 99.1</font></div>

<div style="TEXT-ALIGN: right">&#160;</div>

<div style="TEXT-ALIGN: left">&#160;</div>

<div style="TEXT-ALIGN: left">
<div style="FONT-SIZE: 18pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"><img style="HEIGHT: 58px; WIDTH: 192px" src="image0.jpg">News Release</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">____________________________________________________________________________________</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-TOP: 11.9pt; MARGIN-RIGHT: 39.6pt">Merck Announces Any and All Tender Offers</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-TOP: 10.7pt">Release Date:</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-TOP: 0.2pt">
<div>Monday, November 6, 2017 9:00 am EDT</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-TOP: 10.8pt">Terms:</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"><u>Corporate News Financial News Latest News</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-TOP: 8.1pt">Dateline City:</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-TOP: 0.2pt">KENILWORTH, N.J.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-TOP: 8.3pt">KENILWORTH, N.J.--(<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>BUSINESS WIRE</u></font>)--Merck &amp; Co., Inc. ("Merck") (NYSE:MRK), known as MSD outside the United States and Canada, announced today the commencement of offers to purchase (collectively, the "Offers") any and all of the outstanding notes listed in the table below (collectively, the "Notes"). The Offers are being made upon, and are subject to, the terms and conditions set forth in the Offer to Purchase, dated November 6, 2017 (the "Offer to Purchase").</div>

<div style="MARGIN-BOTTOM: 7.4pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-TOP: 8.7pt">The following table sets forth some of the terms of the Offers, which are more fully set out in the Offer to Purchase:</div>

<table id="z36e41069d05c423fbb0759ffdb6472bd" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 20.38%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Title of Notes</div>
</td>
<td style="WIDTH: 10.67%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">CUSIP</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Number</div>
</td>
<td style="WIDTH: 11.64%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Principal Amount Outstanding</div>
</td>
<td style="WIDTH: 9.7%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Bloomberg Reference Page</div>
</td>
<td style="WIDTH: 15.52%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">U.S. Treasury Reference Security</div>
</td>
<td style="WIDTH: 9.52%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Acceptance Priority Level</div>
</td>
<td style="WIDTH: 7.95%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Fixed</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Spread (Basis Points)</div>
</td>
<td style="WIDTH: 14.62%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Hypothetical</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Total Consideration<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(1)</sup></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.38%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">6.55% Senior Notes due 2037</div>
</td>
<td style="WIDTH: 10.67%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">806605AH4</div>
</td>
<td style="WIDTH: 11.64%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">$524,052,000</div>
</td>
<td style="WIDTH: 9.7%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">FIT1</div>
</td>
<td style="WIDTH: 15.52%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">3.000% due 05/15/47</div>
</td>
<td style="WIDTH: 9.52%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">1</div>
</td>
<td style="WIDTH: 7.95%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">+55</div>
</td>
<td style="WIDTH: 14.62%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">$1,455.37</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.38%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">5.85% Notes due 2039</div>
</td>
<td style="WIDTH: 10.67%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">589331AQ0</div>
</td>
<td style="WIDTH: 11.64%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">$418,907,000</div>
</td>
<td style="WIDTH: 9.7%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">FIT1</div>
</td>
<td style="WIDTH: 15.52%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">3.000% due 05/15/47</div>
</td>
<td style="WIDTH: 9.52%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">2</div>
</td>
<td style="WIDTH: 7.95%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">+60</div>
</td>
<td style="WIDTH: 14.62%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">$1,367.33</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.38%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">6.50% Senior Notes due 2033</div>
</td>
<td style="WIDTH: 10.67%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">806605AG6</div>
</td>
<td style="WIDTH: 11.64%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">$717,611,000</div>
</td>
<td style="WIDTH: 9.7%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">FIT1</div>
</td>
<td style="WIDTH: 15.52%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">3.000% due 05/15/47</div>
</td>
<td style="WIDTH: 9.52%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">3</div>
</td>
<td style="WIDTH: 7.95%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">+45</div>
</td>
<td style="WIDTH: 14.62%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">$1,399.20</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.38%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">5.95% Debentures due 2028</div>
</td>
<td style="WIDTH: 10.67%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">589331AE7</div>
</td>
<td style="WIDTH: 11.64%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">$357,745,000</div>
</td>
<td style="WIDTH: 9.7%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">FIT1</div>
</td>
<td style="WIDTH: 15.52%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">2.250% due 08/15/27</div>
</td>
<td style="WIDTH: 9.52%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">4</div>
</td>
<td style="WIDTH: 7.95%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">+45</div>
</td>
<td style="WIDTH: 14.62%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">$1,296.57</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.38%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">5.75% Notes due 2036</div>
</td>
<td style="WIDTH: 10.67%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">589331AM9</div>
</td>
<td style="WIDTH: 11.64%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">$372,130,000</div>
</td>
<td style="WIDTH: 9.7%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">FIT1</div>
</td>
<td style="WIDTH: 15.52%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">3.000% due 05/15/47</div>
</td>
<td style="WIDTH: 9.52%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">5</div>
</td>
<td style="WIDTH: 7.95%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">+50</div>
</td>
<td style="WIDTH: 14.62%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">$1,338.71</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.38%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">6.40% Debentures due 2028</div>
</td>
<td style="WIDTH: 10.67%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">589331AD9</div>
</td>
<td style="WIDTH: 11.64%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">$326,507,000</div>
</td>
<td style="WIDTH: 9.7%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">FIT1</div>
</td>
<td style="WIDTH: 15.52%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">2.250% due 08/15/27</div>
</td>
<td style="WIDTH: 9.52%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">6</div>
</td>
<td style="WIDTH: 7.95%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">+40</div>
</td>
<td style="WIDTH: 14.62%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">$1,324.42</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.38%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">6.30% Debentures due 2026</div>
</td>
<td style="WIDTH: 10.67%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">589331AC1</div>
</td>
<td style="WIDTH: 11.64%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">$153,077,000</div>
</td>
<td style="WIDTH: 9.7%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">FIT1</div>
</td>
<td style="WIDTH: 15.52%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">2.250% due 08/15/27</div>
</td>
<td style="WIDTH: 9.52%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">7</div>
</td>
<td style="WIDTH: 7.95%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">+40</div>
</td>
<td style="WIDTH: 14.62%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">$1,256.29</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.38%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">5.76% Notes due 2037</div>
</td>
<td style="WIDTH: 10.67%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">58933NAL3</div>
</td>
<td style="WIDTH: 11.64%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">$79,132,000</div>
</td>
<td style="WIDTH: 9.7%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">FIT1</div>
</td>
<td style="WIDTH: 15.52%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">3.000% due 05/15/47</div>
</td>
<td style="WIDTH: 9.52%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">8</div>
</td>
<td style="WIDTH: 7.95%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">+65</div>
</td>
<td style="WIDTH: 14.62%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">$1,320.46</div>
</td>
</tr>
</table>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-TOP: 0.2pt">______________________</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-TOP: 0.2pt">(1) <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Per $1,000 principal amount of Notes, assuming that the Reference Yield (as defined below) had been measured at 11:00 a.m., New York City time, on November 3, 2017 and assuming a hypothetical settlement date of November 15, 2017. The Actual Reference Yield (as defined in the Offer to Purchase) will be determined in accordance with the terms of the Offers. See the Offer to Purchase.</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-TOP: 8.4pt">The Offers will expire at 5:00 p.m. (Eastern time) on November 13, 2017 (such date and time with respect to an Offer, as the same may be extended with respect to such Offer, the &#8220;Expiration Date&#8221;). Notes tendered may be validly withdrawn at any time at or prior to 5:00 p.m. (Eastern time) on November 13, 2017 (such date and time with respect to an Offer, as the same may be extended with respect to such Offer, the &#8220;Withdrawal Date&#8221;), but not thereafter. The &#8220;Settlement Date&#8221; with respect to an Offer will be promptly following the Expiration Date and is expected to be November 15, 2017, which is the second business day after the Expiration Date. The &#8220;Guaranteed Delivery Settlement Date&#8221; with respect to Notes validly tendered pursuant to the guaranteed delivery procedures after the Expiration Date and at or prior to the Guaranteed Delivery Date (as defined in the Offer to Purchase) and accepted for purchase will be the first business day after the Guaranteed Delivery Date and is expected to be November 16, 2017<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">.</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-TOP: 8.4pt">Upon the terms and subject to the conditions set forth in the Offer to Purchase, the consideration for each $1,000 principal amount of each series of Notes validly tendered at or prior to the Expiration Date or the Guaranteed Delivery Date pursuant to the guaranteed delivery procedures, and accepted for purchase (the &#8220;Total Consideration&#8221;), will be payable in cash and will be determined in accordance with standard market practice, as described in the Offer to Purchase, that equates to a yield to maturity equal to the applicable reference yield plus the applicable fixed spread, which reference yield shall be based on the bid-side price of the applicable Reference U.S. Treasury Security specified in the above table at 11:00 a.m. (Eastern time) on November 13, 2017 (such time and date, as the same may be extended with respect to such Offer, the &#8220;Price Determination Date&#8221;). Merck will announce the applicable Total Consideration for each series of Notes as soon as practicable after they are determined by the Dealer Manager on the Price Determination Date.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-TOP: 8.4pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-TOP: 8.4pt">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-TOP: 8.4pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-TOP: 8.4pt">In addition to the applicable Total Consideration, holders whose Notes are accepted for purchase will be paid accrued and unpaid interest on such Notes to, but not including, the Settlement Date. Interest will cease to accrue on the Settlement Date for all Notes accepted, including those tendered through the guaranteed delivery procedures.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-TOP: 8.4pt">Merck&#8217;s obligation to accept Notes tendered in the Offers is subject to the satisfaction of certain conditions described in the Offer to Purchase, including the Complete Purchase Condition (as defined below). Merck reserves the right, subject to applicable law, to waive any and all conditions to any Offer.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-TOP: 8.4pt">Merck&#8217;s obligation to accept and pay for any Notes of any series validly tendered is subject to the terms and conditions set forth in the Offer to Purchase, as it may be amended or supplemented, including, but not limited to, with respect to each series of Notes, $850,000,000 (the &#8220;Maximum Amount&#8221;) being sufficient to fund the aggregate Total Consideration (as defined in the Offer to Purchase) of all Notes of such series (after funding the aggregate Total Consideration of all validly tendered and not validly withdrawn Notes of each series having a higher &#8220;Acceptance Priority Level&#8221; as set forth in the table above (with 1 being the highest Acceptance Priority Level)) tendered in the applicable Offer (the &#8220;Complete Purchase Condition&#8221;). If the Complete Purchase Condition is not satisfied with respect to any series of Notes subject to the Offers, then Merck will not accept for purchase any Notes of that series whether or not validly tendered. Accordingly, upon the terms and subject to the conditions of the Offer, Merck will accept for purchase all Notes of each series tendered in accordance with the applicable Acceptance Priority Level so long as the Maximum Amount is equal to or greater than the aggregate Total Consideration for all tendered Notes of such series and each series having a higher Acceptance Priority Level as further provided in the Offer to Purchase.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-TOP: 8.4pt">Merck has retained BofA Merrill Lynch to act as dealer manager (the &#8220;Dealer Manager&#8221;) for the Offers. Questions regarding terms and conditions of the Offers should be directed to BofA Merrill Lynch at (888) 292-0070 (toll-free) or (980) 387-3907 (collect).</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-TOP: 8.4pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Global Bondholder Services Corporation will act as the Information Agent and the Tender Agent for the Offers. Questions or requests for assistance related to the Offers or for additional copies of the Offer to Purchase may be directed to Global Bondholder Services Corporation at (866) 470-3800 (toll free) or (212) 430-3774 (collect). You may also contact your broker, dealer, commercial bank, trust company or other nominee for assistance concerning the Offers. The Offer to Purchase can be accessed at the following link: </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">http://www.gbsc-usa.com/Merck/</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">.</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-TOP: 8.4pt">If Merck terminates any Offer with respect to one or more series of Notes, it will give prompt notice to the Tender Agent, and all Notes tendered pursuant to such terminated Offer will be returned promptly to the tendering holders thereof. With effect from such termination, any Notes blocked in DTC will be released.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; MARGIN-TOP: 8.4pt">Holders are advised to check with any bank, securities broker or other intermediary through which they hold Notes as to when such intermediary needs to receive instructions from a holder in order for that holder to be able to participate in, or (in the circumstances in which revocation is permitted) revoke their instruction to participate in the Offers before the deadlines specified herein and in the Offer to Purchase. The deadlines set by each clearing system for the submission and withdrawal of tender instructions will also be earlier than the relevant deadlines specified herein and in the Offer to Purchase.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-TOP: 8.4pt">This press release is for informational purposes only. This press release is not an offer to purchase or a solicitation of an offer to purchase any Notes. The Offers are being made solely pursuant to the Offer to Purchase. The Offers are not being made to holders of Notes in any jurisdiction in which the making or acceptance thereof would not be in compliance with the securities, blue sky or other laws of such jurisdiction. In any jurisdiction in which the securities laws or blue sky laws require the Offers to be made by a licensed broker or dealer, the Offers will be deemed to be made on behalf of Merck by the Dealer Manager or one or more registered brokers or dealers that are licensed under the laws of such jurisdiction.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-TOP: 8.1pt">About Merck</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-TOP: 8.25pt">For more than a century, Merck, a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world&#8217;s most challenging diseases. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer&#8217;s disease and infectious diseases including HIV and Ebola.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-TOP: 8.25pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-TOP: 8.25pt">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-TOP: 8.25pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-TOP: 8.25pt">Merck Forward-Looking Statement</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-TOP: 8.25pt; MARGIN-RIGHT: 3.6pt">This news release includes &#8220;forward-looking statements&#8221; within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such statements may include, but are not limited to, Merck&#8217;s ability to complete the offering. These statements are based upon the current beliefs and expectations of Merck&#8217;s management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-TOP: 8.55pt; MARGIN-RIGHT: 10.8pt">Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company&#8217;s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company&#8217;s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-TOP: 8.55pt; MARGIN-RIGHT: 10.8pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Merck undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in Merck&#8217;s 2016 Annual Report on Form 10-K and the company&#8217;s other filings with the SEC available at the SEC&#8217;s Internet site (</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">www.sec.gov</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">).</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-TOP: 25.9pt">Language:</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-TOP: 0.3pt">English</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-TOP: 8.3pt">Contact:</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-TOP: 8.4pt">Merck &amp; Co., Inc.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-TOP: 0.65pt">Media:</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-TOP: 0.15pt">Claire Gillespie, 267-305-0932</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">or</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Investor:</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Amy Klug, 908-740-1898</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-TOP: 8.4pt">Ticker Slug</div>

<div style="MARGIN-BOTTOM: 11.4pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-TOP: 2.6pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Ticker: </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">MRK</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Exchange: </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">NYSE</font></div>

<div><br>
</div>

<div><br>
</div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !N 7(# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MI&8*I9B H&23VH CN+B&TMY+BXE2*&,;G=S@ 5YSK?Q7BBD:'1;438X\^?(4
M_1>I'UQ7*^-?%\OB._,,#LFFPMB-.F\_WS_3T_.N4KMI8=6O,^>QF:R<G"AH
MNYU,_P 1?$\S$C4!$O\ =CA0?J1G]:L6GQ-\26[@S3P72_W985'_ *#BN.HK
M?V4.QYBQF(3OSO[SVOP[\2-,UB1+:]3[#=N=J[CF-S[-V/U_,UVM?+]>J?#?
MQA)<.NA:C*7?!-K*QR2!U0G^7Y>E<M:@DN:)[. S-U)*G6W>S/3****Y3VPH
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI"0 22 !U)H 6N0^).JMIWA
M.6*-]LMXX@&.NT\M^@Q^-3:I\0O#NF.T9NFNI%."ELN_'X\+^M<OJ5W_ ,+0
M:.STL&T%EF5S='[V< 8"Y]_SK:G!IJ4EH>?BL3"5.5*E*\GI9'F%%>@_\*DU
M;_H(67_C_P#A1_PJ35O^@A9?^/\ ^%=GMJ?<^?\ [/Q/\AY]17H/_"I-6_Z"
M%E_X_P#X4?\ "I-6_P"@A9?^/_X4>VI]P_L_$_R'GU2V]Q+:7,5S Y26)PZ,
M.Q!R#7>?\*DU;_H(67_C_P#A1_PJ35O^@A9?^/\ ^%'MJ?<:R_%+509ZMIUX
MFHZ;:WL8PEQ$L@'ID9Q5FO.-/\=6'A6V30-0@N)9K$F%Y;<*5;![9(-=;H_B
MS1-<81V-\C3$?ZEP4?\  'K^&:X94Y+6VA]+1Q5*=H\RYNWF;5%%%9G4%%%%
M !16?KFJIH>B7>IR1-*EM'O**<$UYU_PO#3?^@/=_P#?Q:=A7/5:*\J_X7AI
MO_0'N_\ OXM>G6=W#?V,%Y;MNAGC62,^JD9%*P7)Z**P/%OBJT\(Z4E]=1/,
M9)1&D2$ L<$]^P H&;]%>5?\+PTW_H#W?_?Q:L6'QET^_P!1MK-=)NE:XE6(
M,9%P"Q S^M.S%='IM%87BSQ-#X3T<:C/;R3H95BV(0#D@G//TKA_^%X:;_T!
M[O\ [^+18+GJM%>5?\+PTW_H#W?_ '\6C_A>&F_] >[_ ._BT6871ZK17&^#
M_B%:>,-0GL[>QFMVAB\TM(X((R!CCZUG^(/BO8^']=NM*ETRXE>W8*75U .0
M#_6BP71Z%17E7_"\--_Z ]W_ -_%H_X7AIO_ $![O_OXM%F%T>JT5YUIOQE\
M.W<RQW<-W99_CD0,@_%3G]*] MKJ"]MH[FUFCF@D&Y)(V#*P]C2'<EHHHH *
M*XW7?B?X;T.5X#</>W"]8[4!@#Z%L@?K7'7'QRD)(MM!11V,ER3G\ H_G3L*
MZ/8Z*\<M?CE(&47>A*5[M%<8(_ K_6N\\-^/="\42BWL9I$N]I8V\T>UL#J<
MC(/X&BP71T]%<%XG^*%EX8UV;2IM.N)WB56+HX .X ]_K5?0_BW8:YK=IID>
MEW,3W,FP.SJ0*+!='HM%%4M7U6TT32KC4;V39;P+N;U/H![D\"D,NT5Y5_PO
M#3?^@/=_]_%KH_"/C]/%]]+!:Z3<0Q0INDGD<%5]!QW/]#3L*Z.RHHHI#(KF
MYAL[:2YN)%CAB4L[MT %>(>+?'%[XAG>WMV>WTT'"Q X,@]7]?IT'ZUTOQ7U
MQU^SZ)"<*P$\Y]>2%'Z$_E7EU=N'I*W,SYW-<;)S=&#T6X5V/PTU);#Q='%(
M0$NXVAR?[W!'ZC'XUQU/BE>&5)8F*2(P96'4$=#71./-%H\JA5=*I&:Z'T[1
M7/>$?%$'B72EDRJ7L0"W$0['^\/8_P#UJZ&O+DG%V9]I3J1J14X[,****184
MR::.W@DFE<)'&I=V/0 #)-/KS;XF>*TBMFT&RD#2R?\ 'RRG[B_W/J>_M]:N
M$'.5D88FO&A3<Y'F6I7C:CJEW>L"#<3-)@]LDG%5E9E8,I(8'((/(I**]2Q\
M6VV[L]0\"^/Y9)HM(UF7=N^6"Z<\Y[*Q[^Q_.O4*^7Z][\"ZX^N^&899FW7,
M!\B4GJQ &#^((_'-<6(I*/O(^ARK&RJ?N:CU6QTM%%%<I[1S?Q _Y$+6?^O<
M_P Q7S%7T[\0/^1"UG_KW/\ ,5\Q52)85[U\'-=_M#PS+I<KYFT]\*#U,;9(
M_([A^5>&36DT$%O/(N([A"\;>H#%3^H-=-\-]=_L'QG:.[[;>Z/V:;)XPW0_
M@VT_3-#$CZ4KP+XP:[_:7BE=.B?,&GIL..AD;!;\AM'X&O;M;U2+1-$O-2FQ
MLMHB^"<;CV'XG _&OE.ZN9;V[FNIW+S3.TCL>[$Y)I(;(:TO#O\ R,VD_P#7
MY#_Z&*J26DT-I!<NNV.<L(R?XMN 3],G'X&K?AW_ )&;2?\ K\A_]#%4(]M^
M,O\ R(Z?]?D?_H+5X!7O_P 9?^1'3_K\C_\ 06KP"D@>YTEGX!\47]G#=VND
M226\R!XW$B#<IZ'DU-_PK;Q?_P! 27_OXG_Q5>\^"?\ D1]$_P"O./\ ]!%;
MU*X['DWPI\*:YH&NWMQJFGO;126VQ69U.6W*<<$^E<#\2?\ DH6K_P#71/\
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M!:[/X/ZUJNI^(;Z*_P!3O;N-;3<J3W#2 '>O(!/6N,^)/_)0M7_ZZ)_Z M-
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M ,31_P +$\5?]!7_ ,EXO_B:Y>BN_P!G#LCY;ZU7_G?WLZC_ (6)XJ_Z"O\
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M5*54GN<>IJM#\)O#%O/'/"M['+&P='6X(*D<@BNYHIW%9 .G7-%%%(84444
M%%%% 'C_ (]\#R:=/+JVF1%K)R7FC7K">YQ_=_E]*\_KZ@(!&",@UQVM_#;1
M=6D:>W#6$[<DP@;"?4K_ (8KKI8BRM(\+&92Y2<Z/W?Y'B%%>AS_  CU-2?L
M^HV<@[>8&3^0-3VGPBN3(#>ZI"B=Q#&6)_$XKH]M"U[GEK 8ARY>77U1YO'&
M\LBQQHSR.0JJHR6)Z "O9O /@MM"B.HZ@@_M"5<*F<^2I[?[Q[_EZULZ#X.T
M?P\ ]K!YEQ_S\389_P .P_"M^N6K7YE:.Q[6!RSV+]I4U?Y!1117,>N%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
:%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
